Martin-Fontecha A - Search Results

1

The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.

Iezzi G, Rivolta L, Ronchetti A, Martin-Fontecha A, Rosato A, Protti MP, Sabbadini MG, Bellone M. Iezzi G, et al. Cancer Res. 1997 Jul 1;57(13):2564-8. Cancer Res. 1997. PMID: 9205054

2

Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cells.

Castiglioni P, Martin-Fontecha A, Milan G, Tomajer V, Magni F, Michaelsson J, Rugarli C, Rosato A, Bellone M. Castiglioni P, et al. Cancer Res. 2002 Feb 15;62(4):1116-22. Cancer Res. 2002. PMID: 11861391

3

Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors.

Martin-Fontecha A, Cavallo F, Bellone M, Heltai S, Iezzi G, Tornaghi P, Nabavi N, Forni G, Dellabona P, Casorati G. Martin-Fontecha A, et al. Eur J Immunol. 1996 Aug;26(8):1851-9. doi: 10.1002/eji.1830260828. Eur J Immunol. 1996. PMID: 8765031

4

Rejection of a nonimmunogenic melanoma by vaccination with natural melanoma peptides on engineered antigen-presenting cells.

Bellone M, Iezzi G, Martin-Fontecha A, Rivolta L, Manfredi AA, Protti MP, Freschi M, Dellabona P, Casorati G, Rugarli C. Bellone M, et al. J Immunol. 1997 Jan 15;158(2):783-9. J Immunol. 1997. PMID: 8992995

5

Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.

Cavallo F, Martin-Fontecha A, Bellone M, Heltai S, Gatti E, Tornaghi P, Freschi M, Forni G, Dellabona P, Casorati G. Cavallo F, et al. Eur J Immunol. 1995 May;25(5):1154-62. doi: 10.1002/eji.1830250504. Eur J Immunol. 1995. PMID: 7539748

6

Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1 (CD80) and B7-2 (CD86) discloses the dominant effect of B7-1 in the induction of antitumor immunity.

Martín-Fontecha A, Moro M, Crosti MC, Veglia F, Casorati G, Dellabona P. Martín-Fontecha A, et al. J Immunol. 2000 Jan 15;164(2):698-704. doi: 10.4049/jimmunol.164.2.698. J Immunol. 2000. PMID: 10623812

7

NK cell triggering by the human costimulatory molecules CD80 and CD86.

Wilson JL, Charo J, Martín-Fontecha A, Dellabona P, Casorati G, Chambers BJ, Kiessling R, Bejarano MT, Ljunggren HG. Wilson JL, et al. J Immunol. 1999 Oct 15;163(8):4207-12. J Immunol. 1999. PMID: 10510357

8

The social life of NK cells.

Martín-Fontecha A, Carbone E. Martín-Fontecha A, et al. Arch Immunol Ther Exp (Warsz). 2001;49 Suppl 1:S33-9. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11603867 Review.

9

Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses.

Soderquest K, Walzer T, Zafirova B, Klavinskis LS, Polić B, Vivier E, Lord GM, Martín-Fontecha A. Soderquest K, et al. Among authors: martin fontecha a. J Immunol. 2011 Mar 15;186(6):3304-8. doi: 10.4049/jimmunol.1004122. Epub 2011 Feb 9. J Immunol. 2011. PMID: 21307295

10

Triggering of murine NK cells by CD40 and CD86 (B7-2).

Martín-Fontecha A, Assarsson E, Carbone E, Kärre K, Ljunggren HG. Martín-Fontecha A, et al. J Immunol. 1999 May 15;162(10):5910-6. J Immunol. 1999. PMID: 10229827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters